Pentagon's Funding of Chinese Pathogen Research Remains Murky
Inspector General report reveals significant gaps in tracking U.S. defense funds sent to Chinese labs for potentially dangerous research.
- The Department of Defense cannot fully account for funds allocated to Chinese research laboratories for pathogen-related studies.
- Sen. Joni Ernst and other lawmakers demand greater transparency and accountability from the Pentagon.
- The Inspector General's report highlights limitations in the DoD's financial tracking systems.
- Redactions in the report have raised concerns among lawmakers about hidden collaborations with Chinese biotech firms.
- Calls for a comprehensive audit of U.S. funding for gain-of-function research continue to grow.